WT1 as a Novel Target Antigen for Cancer Immunotherapy
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
45-54
Author(s):
Y. Oka, A. Tsuboi, O. A. Elisseeva, K. Udaka and H. Sugiyama
Sulfonamides and Sulfonylated Derivatives as Anticancer Agents
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
55-75
Author(s):
Angela casini, Andrea Scozzafava, Antonio Mastrolorenzo and Claudiu T. Supuran
Receptor Selective Synthetic Retinoids as Potential Cancer Chemotherapy Agents
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
77-86
Author(s):
D. L. Crowe
Author Index To Volume 1
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
87-87
Author(s):
subject Index To Volume 1
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
89-89
Author(s):
Science Publishers Bentham
The Impact of Thrombopoietin on Clinical Practice
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
369-377
Author(s):
Russell Basser
Cytokines in Haemopoietic Progenitor Mobilisation for Peripheral Blood Stem Cell Transplantation
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
379-394
Author(s):
Robin J.A Filshie
Growth Factors, Cytokines and Dendritic Cell Development
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
405-418
Author(s):
S. Vuckovic, G. J. Clark and D. N.J. Hart
Phage Display as a Tool for Protease Ligand Discovery
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
1-12
Author(s):
Andrew E. Nixon
Application of Phage Display Technology to Cancer Research
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
29-43
Author(s):
Yum L. Yip and Robyn L. Ward